Treatment failure of ofloxacin in Campylobacter pylori infection.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002167:Campylobacter / Q000187:drug effects; D002169:Campylobacter Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004352:Drug Resistance, Microbial; D005500:Follow-Up Studies; D005756:Gastritis / Q000188:drug therapy*; D006801:Humans; D015242:Ofloxacin; D010078:Oxazines / Q000627:therapeutic use*; D011897:Random Allocation
D000900:Anti-Bacterial Agents; D010078:Oxazines; D015242:Ofloxacin